A holder reports 5% or less of Collegium (COLL), with sole voting power over its shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Fuller & Thaler Asset Management, Inc. has filed an amended passive investment disclosure (SCHEDULE 13G/A) for Collegium Pharmaceutical, Inc. (COLL). As of September 30, 2026, the firm reported beneficial ownership of 598,540.14 common shares, representing 1.84% of the class. Fuller & Thaler holds sole voting and sole dispositive power over these shares, indicating ownership of 5% or less.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.